The ECB decision is in 6 days. 3M Euribor swaps are already pricing 2.40%. Markets moved. Most internal models have not.
Rabobank (27 March 2026) explicitly forecasts ECB hike to 2.25% — the only hike forecast among 37 PHM research sources. Rationale: ECB cannot assume inflation returns to target automatically after a supply shock, given 2022 precedent. Markets are pricing this. Internal models are not.
Rabobank may be wrong. But your floating rate liabilities, your EUR fixed income portfolio, your EM revenue exposure — those are running on an assumption that 36 out of 37 sources share, and that the yield curve stopped sharing weeks ago.
The operational cost of running a hike scenario in early April is a planning pass. A senior Treasury FTE for a week, board memo attached, duration numbers refreshed. Call it €50–€100k fully loaded, across the ten largest EUR corporate finance functions.
The operational cost of not running it, if Rabobank is right, is the one corporates absorbed in 2022 — covenant re-test under pressure, refinancing pulled forward into a repriced curve, portfolio mark-downs taken without hedge adjustment. €1.1M per €500M of floating capex is the narrow read. The wide read is what SVB paid for the same deferral.
The test is not whether Rabobank is right. It is whether 36 of 37 consensus can be wrong at the same time. In 2022, they were. The yield curve moved first. Five of the ten European banks that had the sharpest 2022 NIM compression had the same forecast distribution on their desks six months earlier. The consensus is a distribution, not a number. A 3% tail is not zero risk — it is the risk PHM reads as material.
The diagnostic stress-tests your rate and duration assumptions against the Rabobank outlier and returns the delta. Twelve minutes.
Run the diagnostic →